Thus, considering BPC 157/Parkinsons disease/Alzheimers disease, BPC 157 therapy was effective in Parkinsons disease models, and it counteracted parkinsonogenic neurotoxin MPTP-induced tremor, rigor, akinesia, and gastric lesions and counteracted mortality in mice, reserpine-induced akinesia, catalepsy, hypothermia, and catalepsy induced by neuroleptics or NOS-blocker L-NAME application [198,199,200]
Pharmacokinetic profiles for the compound place its plasma half-life in the neighborhood of 45 minutes after parenteral administration in animal models, which informs typical dosing intervals in published experiments
How does vitamin B12 deficiency cause neuropathy
Elevated B12 is more commonly caused by myeloproliferative disorders, certain cancers, renal failure, or excessive supplementation